Major trial questions need for radiation in Intermediate-Risk breast cancer
NCT ID NCT07385365
First seen Feb 04, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study looks at whether women with intermediate-risk breast cancer can safely avoid radiation therapy to the lymph nodes after surgery. About 3,100 participants will be randomly assigned to receive either standard radiation or no radiation. The goal is to see if skipping radiation leads to similar tumor-free survival rates while reducing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital,Chinese Academy od Medical Sciences
Beijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.